Nevertheless, the molecular sites uncovered by the present study would be instrumental in pinpointing the dyclonine-TRPV3 interaction at the molecular level, thereby developing specific therapeutics for chronic pruritus, dermatitis, and skin inflammations. This evidence concerns the gene TRPV3 and dermatitis.